Zotefoams plc provided group sales guidance for the full year of 2013. For the period, the company expects to see growth in HPP and MEL, although overall group sales are expected to show a decline of approximately 5% compared with 2012, mainly as a result of lower polyolefin sales in continental Europe.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
439 GBX | +2.09% | +2.09% | +31.04% |
May. 07 | Abingdon Health buys IVDeology Holdings | AN |
Apr. 26 | Record up on "milestone"; Zotefoams down | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+31.04% | 262M | |
+5.76% | 105B | |
-3.95% | 63.99B | |
+51.90% | 42.95B | |
+17.44% | 39.2B | |
+6.62% | 33.01B | |
+13.00% | 20.33B | |
+15.64% | 17.29B | |
+22.55% | 15.72B | |
+7.34% | 14.72B |
- Stock Market
- Equities
- ZTF Stock
- News Zotefoams plc
- Zotefoams plc Provides Group Sales Guidance for the Full Year of 2013